1-3 of 3
Leonardo A Meza-zepeda
Close
Sort by
Journal Articles

Discovery of Recurrent Mutations Associated with Chemo-Immunotherapy Relapse in Diffuse Large B-Cell Lymphoma

Jillian Frances Wise, PhD, Sigve Nakken, PhD, Daniel Vodak, BS, Gunhild Trøen, PhD, Ole Christian Lingjærde, PhD, Leonardo A. Meza-Zepeda, PhD, Ola Myklebost, PhD, Klaus Beiske, MD PhD, June Helen Myklebust, PhD, Eivind Hovig, PhD, Erlend Smeland, MD PhD, Harald Holte, Jr., MD PhD
Journal: Blood
Blood (2015) 126 (23): 110.
https://doi.org/10.1182/blood.V126.23.110.110
Published: 2015
Journal Articles

Clinical and Biological Implications of BRAF V600E Mutation in Multiple Myeloma

Even Holth Rustad, Hong Yan Dai, PhD, Haakon Hov, MDPhD, Eivind Coward, PhD, Vidar Beisvag, PhD, Ola Myklebost, MDPhD, Eivind Hovig, PhD, Sigve Nakken, PhD, Daniel Vodák, Leonardo A Meza-Zepeda, PhD, Arne K Sandvik, MDPhD, Karin Fahl Wader, MD PhD, Kristine Misund, PhD, Anders Sundan, PhD, Harald Aarset, MDPhD, Anders Waage, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5685.
https://doi.org/10.1182/blood.V124.21.5685.5685
Published: 2014
Journal Articles

OH-2, a Hyperdiploid Myeloma Cell Line without An IGH Translocation, Has a Complex Translocation Juxtaposing MYC near MAFB and the IGK Locus

Thea Kristin Våtsveen, Erming Tian, Stine H Kresse, Leonardo A Meza-zepeda, Ana Gabrea, Hong Yan Dai, Michael Kuehl, MD, Anders Sundan, Magne Borset, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2736.
https://doi.org/10.1182/blood.V112.11.2736.2736
Published: 2008